CVF Capital Partners Supports the Acquisition of Cordant Health Solutions
April 10, 2023 | | By: CVF Capital Partners

CVF and DCA co-invest into Cordant Health Solutions
FLAGSTAFF, AZ (April 10, 2023) – CVF Capital Partners (“CVF”) alongside DCA Capital Partners supported the acquisition of the Toxicology Direct Bill (“Direct Bill”) division of Cordant Health Solutions (“CHS”). The Direct Bill division provides drug testing and lab services for parole agencies, probation and drug courts as well as medication-assisted and abstinence clinics.